Clinical effect of ranitidine in psoriasis. An open prospective study;KLINISK EFFEKT AF RANITIDIN VED PSORIASIS. ET AABENT PROSPEKTIVT STUDIE

Ugeskrift for Laeger

Volumn 159, Issue 5, 1997, Pages 598-600

  Nielsen, Hans Jørgen ^a   Kristensen, Johannes K ^b   Hansen, Ulla ^b   Nielsen, Henrik Ib ^b   Skov, Per Stahl ^b   Petersen, Lars M Jelstrup ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PSORIASIS; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; RANITIDINE;

EID: 0031029958     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wallach D, Cottenot F. Cimetidine versus placebo in the treatment of psoriasis. Dermatologica 1982; 165: 197-203.
2. Merk H, Goerz G, Runne U, Kurka M, Schäfer J, Brendel E. Cimetidine and chlorpheniramine in the treatment of psoriasis. Dermatologica 1983; 166: 94-6.
3. Nielsen HJ. Histamine and histamine type-2 receptor antagonists in psoriasis. Mechanisms and speculations. Dan Med Bull 1991; 38: 478-80.
4. Nielsen HJ, Nielsen H, Georgsen J. Ranitidine for improvement of treatment resistant psoriasis. Arch Dermatol 1991; 127: 270.
5. Stashower ME, Yaeger JK, Smith KJ, Skelton HG, Wagner KF. Cimetidine as therapy for treatment-resistant psoriasis in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1993; 129: 848-50.
6. Nielsen HJ. Possible role of histamine type-2 receptor antagonists on posttraumatic immune competence. Dan Med Bull 1995; 42: 162-74.
7. Nielsen HJ, Hammer JH, Rasmussen SG, Monrad H, Grindsted J, Nielsen H et al. The effect of ranitidine on immune function, tumor response and survival in patients with liver metastases from colorectal cancer. GI Cancer 1996; 1: 183-90.
8. Witkamp L, Velthuis PJ, Verhaegh MJ, Hulsmans RFHJ, Bossuyt PM, Bos JD et al. An open prospective clinical trial with systemic ranitidine in the treatment of psoriasis. J Am Acad Dermatol 1993; 28: 778-81.
9. Petersen LJ, Kristensen JK. Selection of patients for psoriasis clinical trials: a survey of the recent dermatological literature. J Dermatol Treat 1992; 3: 171-6.
10. Marks R, Barton SP, Shuttleworth D, Finlay AY. Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125: 23540.
11. Andersen B, Holm P. Problems with p. Significance testing in medical research. Copenhagen: F Hoffman-La Roche, 1984: 63-72.
12. Nielsen HJ, Hammer JH. Possible role of histamine in pathogenesis of autoimmune disease: implications for immunotherapy. Med Hypotheses 1992; 39: 349-55.
13. Nielsen HJ. Role of histamine in the pathogenesis of autoimmune disease. Implication for drug therapy. Clin Immunother 1994; 1: 250-7.
14. Pedersen C, Permin H, Skov PS, Norn S, Svenson M, Mosbech H et al. Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells. Allergy 1985; 40: 103-7.
15. Nolle H, Skov PS. Inhibition of basophil histamine release by methotrexate. Agents Actions 1988; 23: 173-6.